More research is required to validate the nutritional regulation of TM6SF2, and large-scale RCTs as well are needed in order to clarify the potential interaction of PUFAs/total fat/carbohydrate intake and TM6SF2 polymorphism in NAFLD and its related traits. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.